BIOXYTRAN, INC·5

Feb 8, 2:00 PM ET

PLATT DAVID 5

5 · BIOXYTRAN, INC · Filed Feb 8, 2023

Insider Transaction Report

Form 5
Period: 2022-12-31
PLATT DAVID
DirectorCEO10% Owner
Transactions
  • Discretionary Transaction

    common

    2022-12-31$0.00/sh+1,900,266$3,8014,097,831 total(indirect: by NDPD Pharma, Inc.)
  • Gift

    warrant

    2022-05-13$0.36/sh122,000$43,9200 total(indirect: by NDPD Pharma, Inc.)
    Exercise: $2.00From: 2019-10-23Exp: 2024-10-23common (122,000 underlying)
  • Gift

    common

    2020-01-07+0411,300 total(indirect: By Spouse)
  • Award

    common

    2018-09-21+043,027,274 total
Footnotes (1)
  • [F1]Management ownership in BIXT by NDPD Pharma, Inc. is consolidated under indirect ownership within Davis Platt's filing

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT